FLUORESCENCE DIAGNOSIS FOR RECURRENT BLADDER CANCER
Abstract
The clinical case of successful use of local fluorescence spectroscopy combined with fluorescence imaging during cystoscopy for diagnosis of recurrent bladder cancer is represented in the article. Histological study of fluorescent foci confirmed tumor growth (urothelial carcinoma) in all areas with high levels of diagnostic parameter. In the fluorescent focus with low diagnostic parameter inflammation was detected.
About the Authors
R. V. Ulyanov
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
A. D. Kaprin
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Zlokachestvennye novoobrazovaniya v Rossii v 2014 godu (zabolevaemost' i smertnost') [Malignant neoplasms in Russia in 2014 (incidence and mortality)], by eds. Kaprin A.D., Starinskii V.V., Petrova G.V. Moscow, MNIOI im. P.A. Gertsena Publ., 2016. 250 p.
2. Kamat A.M., Bağcıoğlu M., Huri E. What is new in non-muscleinvasive bladder cancer in 2016? Turkish Journal of Urology, 2017, Vol. 43(1), pp. 9-13.
3. Cookson M.S., Herr H.W., Zhang Z.F., Soloway S., Sogani P.C., Fair W.R. The treated natural history of high risk superficial bladder cancer: 15-year outcome, J Urol., 1997, Vol. 158, pp. 62-67.
4. Shadpour P., Emami M., Haghdani S. A Comparison of the Progression and Recurrence Risk Index in Non-Muscle-Invasive Bladder Tumors Detected by Narrow-Band Imaging Versus White Light Cystoscopy, Based on the EORTC Scoring System, Nephrourol Mon., 2016, Vol. 8. e33240.
5. Isfoss B.L. The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard, BJU Int, 2011, Vol. 108, pp. 1703- 1707.
6. Lerner S.P., Liu H., Wu M.-F., Thomas Y.K., Witjes J.A. Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder, Urol Oncol, 2012, Vol. 30, pp. 285-289.
7. Adiyat K.T., Katkoori D., Soloway C.T., De los Santos R., Manoharan M., Soloway M.S. ‘Complete transurethral resection of bladder tumor’ are the guidelines being followed? Urology, 2010, Vol. 75, pp. 365-367.
8. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors, J Urol, 1999, Vol. 162, pp. 74-76.
9. Rusakov I.G., Teplov A.A., Uljanov R.V., Filonenko E.V. Fluorescence cystoscopy in patients with non-muscle invasive bladder cancer, Biomedical Photonics, 2015, Vol. 4, No. 3, pp. 29-35. (In Russian)
10. Filonenko E.V. Fluorescence diagnostics and photodynamic therapy: justification of applications and opportunities in oncology, Biomedical Photonics, 2014, Vol. 3, No. 1, pp. 3-7. (In Russian)
11. Filonenko E.V., Grishaeva A.B. Methodological aspects of the fluorescence diagnosis of malignancies by using alasens, Rossiiskii onkologicheskii zhurnal, 2011, No. 5, pp. 30-33. (In Russian)
12. Chissov V.I., Sokolov V.V., Bulgakova (Zharkova) N., Filonenko E.V. Fluorescence endoscopy, dermascopy and spectrophotometry for diagnosis of malignant tumors, Rossiiskii bioterapevticheskii zhurnal, 2003, Vol. 2, No. 4, pp. 46-56. (In Russian)
13. Filonenko E.V., Kaprin A.D., Alekseev B.Y., Apolikhin O.I., Slovokhodov E.K., Ivanova-Radkevich V.I., Urlova A.N. 5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial), Photodiagnosis and Photodynamic Therapy, 2016, Vol. 16, pp. 106-109. doi: 10.1016/j.pdpdt.2016.09.009
Review
For citations:
Ulyanov R.V., Kaprin A.D. FLUORESCENCE DIAGNOSIS FOR RECURRENT BLADDER CANCER. Biomedical Photonics. 2017;6(1):38-40. (In Russ.)
Views:
840
Email this article 